Jane Street’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-26,800
Closed -$114K – 11641
2026
Q2
$114K Sell
26,800
-58,100
-68% -$266K ﹤0.01% 10524
2026
Q1
$394K Buy
84,900
+70,100
+474% +$401K ﹤0.01% 8584
2025
Q4
$105K Buy
+14,800
New +$109K ﹤0.01% 10165

Other funds holding BCYC

Jane Street's BCYC Position: Q3 2026 in Review

Jane Street reduced its Bicycle Therapeutics (BCYC) stake by 83% in Q3 2026, selling an estimated $1.32M and leaving 65,575 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #9665.

Jane Street first reported a position in BCYC in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.66M in Q2 2026. 90 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • Jane Street held 65,575 shares of Bicycle Therapeutics worth $241K as of Q3 2026.
  • Jane Street sold 326,588 Bicycle Therapeutics shares in Q3 2026, an estimated $1.32M.
  • Bicycle Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9665 holding.
  • Jane Street first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 15 quarters since.
  • Jane Street's Bicycle Therapeutics position peaked at $1.66M in Q2 2026.
  • 90 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.